SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
1-Year Return
18.59%
This Quarter Return
-11.65%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$3.7B
AUM Growth
-$587M
(-14%)
Cap. Flow
-$267M
Cap. Flow
% of AUM
-7.22%
Top 10 Holdings %
Top 10 Hldgs %
51.24%
Holding
83
New
45
Increased
6
Reduced
13
Closed
18
Top Buys
| 1 |
Charter Communications
CHTR
|
+$162M |
| 2 |
Union Pacific
UNP
|
+$160M |
| 3 |
McKesson
MCK
|
+$132M |
| 4 |
IQVIA
IQV
|
+$113M |
| 5 |
Boston Scientific
BSX
|
+$93.6M |
Top Sells
| 1 |
Sony
SONY
|
+$158M |
| 2 |
Tyson Foods
TSN
|
+$143M |
| 3 |
Altria Group
MO
|
+$143M |
| 4 |
Lowe's Companies
LOW
|
+$142M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$133M |
Sector Composition
| 1 | Technology | 27.19% |
| 2 | Healthcare | 25.78% |
| 3 | Industrials | 19.73% |
| 4 | Consumer Discretionary | 16.42% |
| 5 | Communication Services | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Insmed
INSM
$30.8B
| $1.07M | 0.03% |
+66,600
| New | +$1.07M |
|
52
Iovance Biotherapeutics
IOVA
$821M
| $898K | 0.02% |
+30,000
| New | +$898K |
|
53
KalVista Pharmaceuticals
KALV
$708M
| $874K | 0.02% |
+114,200
| New | +$874K |
|
54
Sutro Biopharma
STRO
$74.3M
| $826K | 0.02% |
+81,000
| New | +$826K |
|
|
ALBO
55
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $802K | 0.02% |
+49,000
| New | +$802K |
|
56
Regenxbio
RGNX
$465M
| $674K | 0.02% |
+20,820
| New | +$674K |
|
|
CCXI
57
DELISTED
ChemoCentryx, Inc.
CCXI
| $643K | 0.02% |
+16,000
| New | +$643K |
|
58
Puma Biotechnology
PBYI
$225M
| $603K | 0.02% |
+71,500
| New | +$603K |
|
59
Apellis Pharmaceuticals
APLS
$3.14B
| $579K | 0.02% |
+21,600
| New | +$579K |
|
60
Immunovant
IMVT
$2.82B
| $562K | 0.02% |
+36,100
| New | +$562K |
|
61
Heron Therapeutics
HRTX
$193M
| $475K | 0.01% |
+40,500
| New | +$475K |
|
62
argenx
ARGX
$46.3B
| $437K | 0.01% |
+3,320
| New | +$437K |
|
63
Kezar Life Sciences
KZR
$28.9M
| $392K | 0.01% |
+8,990
| New | +$392K |
|
64
Arvinas
ARVN
$568M
| $228K | 0.01% |
+5,650
| New | +$228K |
|
65
Baxter International
BAX
$12.3B
| – | – |
-1,259,570
| Closed | -$105M |
|
|
66
Canadian Pacific Kansas City
CP
$68.9B
| – | – |
-2,610,550
| Closed | -$133M |
|
67
DuPont de Nemours
DD
$32.4B
| – | – |
-1,070,560
| Closed | -$68.7M |
|
68
Elevance Health
ELV
$70.2B
| – | – |
-411,750
| Closed | -$124M |
|
69
Fair Isaac
FICO
$37.1B
| – | – |
-130,170
| Closed | -$48.8M |
|
70
KB Home
KBH
$4.48B
| – | – |
-506,417
| Closed | -$17.4M |
|
|
71
Lowe's Companies
LOW
$152B
| – | – |
-1,188,380
| Closed | -$142M |
|
72
Medtronic
MDT
$121B
| – | – |
-874,650
| Closed | -$99.2M |
|
73
3M
MMM
$84.1B
| – | – |
0
| – | – |
|
|
74
Altria Group
MO
$112B
| – | – |
-2,861,740
| Closed | -$143M |
|
75
NVR
NVR
$23.3B
| – | – |
-9,020
| Closed | -$34.4M |
|